Who is sponsoring NCT03059186?

NCT03059186 is sponsored by University of Sheffield.

What drugs are being tested in NCT03059186?

Interventions in NCT03059186: Gratitude diary.

What condition does NCT03059186 study?

NCT03059186 studies Inflammatory Bowel Diseases.

Is NCT03059186 still recruiting?

NCT03059186 is currently completed. Last updated 9 August 2018.

Last reviewed 2018-08-09 · How we verify

NCT03059186

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Gratitude Intervention in Improving Well-being and Coping in People Living With Inflammatory Bowel Disease

Completed NA Last updated 9 August 2018

What this trial tests

NA trial testing Gratitude diary in Inflammatory Bowel Diseases in 129 participants. Completed in 1 June 2018.

Timeline

6 June 2017

Primary endpoint
1 June 2018

1 June 2018

Quick facts

Lead sponsor	University of Sheffield
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	129
Start date	6 June 2017
Primary completion	1 June 2018
Estimated completion	1 June 2018
Sites	1 location across United Kingdom

Drugs / interventions tested

Gratitude diary

Conditions studied

Inflammatory Bowel Diseases — all drugs for Inflammatory Bowel Diseases →

Sponsor

University of Sheffield

Who can join

16 and older, any sex, with Inflammatory Bowel Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of the proposed research is to investigate the extent to which a one-week online gratitude intervention can improve levels of wellbeing in individuals living with Inflammatory Bowel Disease (IBD). A secondary aim was to investigate the extent to which dispositional gratitude influences levels of coping and wellbeing and to what extent this mediates the effect of the intervention. Participants with IBD will be randomized to either treatment or control group. Participants will complete measures pre- and post- intervention, and follow-up (eight weeks) measuring: gratitude (state and trait), illness severity, mood, stress and coping.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Patient education interventions for the management of inflammatory bowel disease.
Gordon M, Sinopoulou V, Ibrahim U, Abdulshafea M, et al · · 2023 · cited 16× · PMID 37172140 · DOI 10.1002/14651858.cd013854.pub2
Remote care through telehealth for people with inflammatory bowel disease.
Gordon M, Sinopoulou V, Lakunina S, Gjuladin-Hellon T, et al · · 2023 · cited 16× · PMID 37140025 · DOI 10.1002/14651858.cd014821.pub2
Psychological interventions for treatment of inflammatory bowel disease.
Tiles-Sar N, Neuser J, de Sordi D, Baltes A, et al · · 2025 · cited 5× · PMID 40243391 · DOI 10.1002/14651858.cd006913.pub3

Verify or expand the search:

Other recruiting trials for Inflammatory Bowel Diseases

Currently open trials in the same condition.

NCT07520747 — A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea · recruiting
NCT07349472 — Pentoxifylline in Patients With Ulcerative Colitis · Phase 2 · recruiting
NCT07033208 — Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance · NA · recruiting
NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting

Other University of Sheffield trials

Trials by the same sponsor.

NCT07049042 — Hypogonadotrophic Hypogonadism in Genetic Neurodevelopmental Conditions · recruiting
NCT07132879 — Telehealth in MND-Research (TIM-R): A Research Database for MND · recruiting
NCT06628427 — Unlock the Secrets of Ageing Brains Through P300 Brain-computer Interface Games · not yet recruiting
NCT06476483 — Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit · NA · completed
NCT06508840 — The Clear Conversations Project · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03059186 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sheffield
Last refreshed: 9 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03059186.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing